Knockdown of CHPF suppresses cell progression of non-small-cell lung cancer

Area of Science:

• Oncology
• Molecular Biology
• Gene Therapy

Background:

• Non-small-cell lung cancer (NSCLC) is a leading cause of cancer-related mortality worldwide.
• Identifying novel therapeutic targets is crucial for improving NSCLC treatment outcomes.

Purpose of the Study:

• To investigate the role of the CHPF gene in the development and progression of NSCLC.
• To develop and evaluate an shRNA vector-based therapy for repressing CHPF gene expression in NSCLC cell lines.

Main Methods:

• Immunohistochemical staining to assess CHPF expression in NSCLC tissues.
• RT-PCR and Western blotting to quantify CHPF gene expression in NSCLC cell lines.
• Utilizing CHPF-specific shRNA for gene knockdown and assessing effects on cell proliferation, apoptosis, and cell cycle via Celigo image cytometry, cell cycle analysis, and flow cytometry.

Main Results:

• CHPF expression was found to be significantly upregulated in NSCLC tissues compared to normal lung tissues.
• Knockdown of CHPF expression in NSCLC cells led to substantial inhibition of cell proliferation.
• CHPF knockdown also significantly impacted apoptosis and cell cycle progression in vitro.

Conclusions:

• CHPF plays a critical role in the progression of human NSCLC.
• Targeting CHPF expression through gene interference presents a potential therapeutic strategy for NSCLC treatment.